These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26296371)

  • 21. In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation.
    Neal RE; Millar JL; Kavnoudias H; Royce P; Rosenfeldt F; Pham A; Smith R; Davalos RV; Thomson KR
    Prostate; 2014 May; 74(5):458-68. PubMed ID: 24442790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.
    Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C
    Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation.
    Ren F; Li Q; Hu L; Yan X; Gao Z; Zhang J; Gao W; Zhang Z; Chang P; Chen X; Chu D; Wu R; Lv Y
    Surg Endosc; 2020 Feb; 34(2):580-589. PubMed ID: 31011863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-TRUS fusion for electrode positioning during irreversible electroporation for treatment of prostate cancer.
    Baur ADJ; Collettini F; Enders J; Maxeiner A; Schreiter V; Stephan C; Gebauer B; Hamm B; Fischer T
    Diagn Interv Radiol; 2017; 23(4):321-325. PubMed ID: 28508759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of irreversible electroporation of prostate cancer on microcirculation: Imaging findings in contrast-enhanced T1-weighted 3D MRI.
    Beyer LP; Pregler B; Verloh N; Brünn K; Haimerl M; Stroszczynski C; Jung EM; Wiggermann P
    Clin Hemorheol Microcirc; 2017; 67(3-4):399-405. PubMed ID: 28885207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. First Human Trial of High-Frequency Irreversible Electroporation Therapy for Prostate Cancer.
    Dong S; Wang H; Zhao Y; Sun Y; Yao C
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789692. PubMed ID: 30045668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Irreversible electroporation ablation: is all the damage nonthermal?
    Faroja M; Ahmed M; Appelbaum L; Ben-David E; Moussa M; Sosna J; Nissenbaum I; Goldberg SN
    Radiology; 2013 Feb; 266(2):462-70. PubMed ID: 23169795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes.
    Blazevski A; Gondoputro W; Scheltema MJ; Amin A; Geboers B; Barreto D; Haynes AM; Shnier R; Delprado W; Agrawal S; Thompson JE; Stricker PD
    BMC Urol; 2022 Mar; 22(1):28. PubMed ID: 35236338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible Electroporation for the Ablation of Prostate Cancer.
    Karagiannis A; Varkarakis J
    Curr Urol Rep; 2019 Sep; 20(10):63. PubMed ID: 31478109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible electroporation: a new ablation modality--clinical implications.
    Rubinsky B; Onik G; Mikus P
    Technol Cancer Res Treat; 2007 Feb; 6(1):37-48. PubMed ID: 17241099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Irreversible Electroporation Ablation as Adjunctive Treatment for Margin Enhancement: Safety and Efficacy.
    Simmerman E; Chung J; Lawson A; Kruse E
    J Surg Res; 2020 Feb; 246():260-268. PubMed ID: 31610354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.
    Yaxley WJ; Gianduzzo T; Kua B; Oxford R; Yaxley JW
    Investig Clin Urol; 2022 May; 63(3):285-293. PubMed ID: 35534217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
    Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
    Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Irreversible electroporation (IRE) : A minimally invasive therapeutic option in prostate cancer].
    Wiggermann P; Brünn K; Bäumler W
    Radiologe; 2017 Aug; 57(8):637-640. PubMed ID: 28477079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focal Therapy of Prostate Cancer Using Irreversible Electroporation.
    Valerio M; Ahmed HU; Emberton M
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):147-52. PubMed ID: 26365544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling of a single bipolar electrode with tines for irreversible electroporation delivery.
    Zhao Y; McKillop IH; Davalos RV
    Comput Biol Med; 2022 Mar; 142():104870. PubMed ID: 35051854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol.
    Wagstaff PG; de Bruin DM; Zondervan PJ; Savci Heijink CD; Engelbrecht MR; van Delden OM; van Leeuwen TG; Wijkstra H; de la Rosette JJ; Laguna Pes MP
    BMC Cancer; 2015 Mar; 15():165. PubMed ID: 25886058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing Irreversible Electroporation Ablation with a Bipolar Electrode.
    Wandel A; Ben-David E; Ulusoy BS; Neal R; Faruja M; Nissenbaum I; Gourovich S; Goldberg SN
    J Vasc Interv Radiol; 2016 Sep; 27(9):1441-1450.e2. PubMed ID: 27475242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Induction of Combined Hyperthermal Ablation Effect of Irreversible Electroporation with Polydopamine Nanoparticle-Coated Electrodes.
    Jeon SM; Davaa E; Jenjob R; Pechyen C; Natphopsuk S; Jeong S; Yoo HJ; Yang SG
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective development study investigating focal irreversible electroporation in men with localised prostate cancer: Nanoknife Electroporation Ablation Trial (NEAT).
    Valerio M; Dickinson L; Ali A; Ramachandran N; Donaldson I; Freeman A; Ahmed HU; Emberton M
    Contemp Clin Trials; 2014 Sep; 39(1):57-65. PubMed ID: 25072507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.